Mauricio Andrés Martínez Ramírez, Sandra Milena Sanchez Gutiérrez, Yuly Natalia Guzmán Yara, Karol Zeleny Pinzón Jaime, Silvia Carolina Rueda Cataño, Laura Fernanda Sarmiento Bocanegra, Luisa Cristina Sánchez Marín, Sara María Lasprilla Villalobos
{"title":"Treatment approach to a patient with catamenial epilepsy. Case report","authors":"Mauricio Andrés Martínez Ramírez, Sandra Milena Sanchez Gutiérrez, Yuly Natalia Guzmán Yara, Karol Zeleny Pinzón Jaime, Silvia Carolina Rueda Cataño, Laura Fernanda Sarmiento Bocanegra, Luisa Cristina Sánchez Marín, Sara María Lasprilla Villalobos","doi":"10.15446/cr.v8n1.91649","DOIUrl":null,"url":null,"abstract":"Introduction: Catamenial epilepsy refers to the worsening or exacerbation of seizures due to hormonal changes during the menstrual cycle. It is thought to be secondary to the neuroactive properties of endogenous steroid hormones and the natural cyclic variation in their serum levels throughout the menstrual cycle.\nCase presentation: A 31-year-old female patient from Bogotá (Colombia) was admitted to the emergency department due to an episode of tonic-clonic seizure associated with the menstrual period. Since the onset of the seizures was related to menstruation (every 28 days), it was established that the patient had structural focal epilepsy with catamenial features. Advantages of medical vs. surgical treatment were discussed during a multidisciplinary medical board and it was decided to start pharmacological treatment with progestogens, which resulted in complete remission of the seizures as established during a follow-up visit.\nConclusions: Catamenial epilepsy should be considered as a cause of epilepsy refractory to antiepileptic medications. Furthermore, it should be approached from a multidisciplinary perspective and its management should be focused on improving the patients’ quality of life.","PeriodicalId":73637,"journal":{"name":"Journal of cardiology case reports","volume":"38 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cardiology case reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15446/cr.v8n1.91649","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Catamenial epilepsy refers to the worsening or exacerbation of seizures due to hormonal changes during the menstrual cycle. It is thought to be secondary to the neuroactive properties of endogenous steroid hormones and the natural cyclic variation in their serum levels throughout the menstrual cycle.
Case presentation: A 31-year-old female patient from Bogotá (Colombia) was admitted to the emergency department due to an episode of tonic-clonic seizure associated with the menstrual period. Since the onset of the seizures was related to menstruation (every 28 days), it was established that the patient had structural focal epilepsy with catamenial features. Advantages of medical vs. surgical treatment were discussed during a multidisciplinary medical board and it was decided to start pharmacological treatment with progestogens, which resulted in complete remission of the seizures as established during a follow-up visit.
Conclusions: Catamenial epilepsy should be considered as a cause of epilepsy refractory to antiepileptic medications. Furthermore, it should be approached from a multidisciplinary perspective and its management should be focused on improving the patients’ quality of life.